Benzatropine

ADVERTISEMENT

Identification

Molecular formula
C21H25NO2
CAS Number
86-13-5
IUPAC Name
(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl) 2,2-diphenylacetate
Molecular Weight
339.44g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2000g/cm3
Synonyms
2291-55-6
Interesting facts

Interesting Facts about (9-methyl-9-azabicyclo[3.3.1]nonan-3-yl) 2,2-diphenylacetate

(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl) 2,2-diphenylacetate is a fascinating compound that showcases the complexities and wonders of organic chemistry. Here are some notable aspects of this intriguing molecule:

  • Structural Complexity: This compound features a bicyclic structure, which adds to its stereochemistry and molecular interactions — properties that are crucial in medicinal chemistry.
  • Safety and Efficiency: It has been studied for its potential use in various pharmacological applications. Compounds with similar structures have shown promise in enhancing the efficacy of drugs while minimizing side effects.
  • Mechanism of Action: The presence of the azabicyclo framework allows this compound to interact with biological targets, making it a subject of interest for researchers focusing on drug design.
  • Potential Uses: While the specific applications of this compound might still be under research, derivatives of bicyclic amines have previously been explored in areas such as:
    • Pain management
    • Neurological disorders
    • Antidepressant formulations
  • Research Opportunities: The unique structure provides ample room for further investigation. Researchers are encouraged to explore its chemical reactivity, potential derivatives, and efficacy as a drug.

In summary, the nuanced structure of (9-methyl-9-azabicyclo[3.3.1]nonan-3-yl) 2,2-diphenylacetate presents exciting possibilities both in basic research and applied fields. As scientists continue to delve deeper into its properties, this compound could play a pivotal role in advancing our understanding of chemical interactions within biological systems.

ADVERTISEMENT